Quantcast
Last updated on April 18, 2014 at 15:29 EDT

Latest Early prostate cancer antigen-2 Stories

2013-03-18 20:59:04

The digital rectal exam is an important screening test that can discover prostate cancer that a prostate-specific antigen or PSA test may not, despite the higher sensitivity of the PSA test, according to Penn State College of Medicine researchers. The digital rectal examination is a procedure where a physician feels the surface of the prostate with a gloved finger. The doctor is able to feel any lumps or hard areas on the prostate. A PSA test checks for levels of prostate-specific...

2012-06-02 23:01:52

The California Prostate Cancer Coalition Opposes US Task Force Prostate Cancer Testing Recommendation Century City, CA (PRWEB) June 02, 2012 The California Prostate Cancer Coalition (CPCC) is strongly opposing the U.S. Preventive Services Task Force´s (USPSTF) final recommendation (May 22, 2012) against the use of prostate-specific antigen (PSA) testing for the early detection of prostate cancer. The PSA test, used in conjunction with a digital rectal examination (DRE), is the only...

2012-05-28 09:48:07

Physicians have trouble stopping PSA tests, despite questionable benefits Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter serious pushback from primary care physicians, according to results of a survey by Johns Hopkins investigators. In a survey of 125 primary care doctors, the researchers found that while doctors agreed with...

2012-03-15 17:20:00

TALLAHASSEE, Fla., March 15, 2012 /PRNewswire/ -- In a comprehensive study published today in the New England Journal of Medicine, PSA screening was shown to reduce the mortality rate of prostate cancer by 29 percent. The Large Urology Group Practice Association (LUGPA), representing more than 1,800 urologists, stated that today's study confirmed what urologists and other healthcare providers have known for years -- that PSA-based screening is a critical, valuable...

2012-02-02 22:31:10

New study shows benefits of novel PSA velocity risk count testing for prostate cancer A new study by NYU Langone Medical Center and Northwestern University Feinberg School of Medicine shows novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinically significant prostate cancer. The new study, published online by the British Journal of Urology International on February 1, 2012, shows the benefits of tracking a man's PSA levels...

2012-01-20 11:51:00

NEW YORK, Jan. 20, 2012 /PRNewswire/ -- The annual PSA debate wages on in 2012 as further data challenging the effectiveness of routine prostate cancer screening and its impact on prostate cancer deaths is published. The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO), the same group upon which the United States Preventative Services Task Force based their 2011 anti-PSA recommendations, maintains their claim that the Prostate-Specific Antigen (PSA) test does...

2012-01-12 12:50:53

After a 20-year quest to find a genetic driver for prostate cancer that strikes men at younger ages and runs in families, researchers have identified a rare, inherited mutation linked to a significantly higher risk of the disease. A report on the discovery, published in the January 12, 2012 issue of the New England Journal of Medicine, was led by investigators at the Johns Hopkins University School of Medicine and the University of Michigan Health System. The research team found that men...

2012-01-11 16:00:00

Discovery may provide clues on disease development and who may need earlier screening ANN ARBOR, Mich., Jan. 11, 2012 /PRNewswire-USNewswire/ -- After a 20-year quest to find a genetic driver for prostate cancer that strikes men at younger ages and runs in families, researchers have identified a rare, inherited mutation linked to a significantly higher risk of the disease. A report on the discovery, published in the January 12, 2012, issue of the New England Journal of Medicine,...

2011-08-15 15:29:51

Novel assay found to be more accurate than traditional screening A new prostate screening test developed by AnalizaDx, Inc., a Cleveland-based biotech company, and studied by researchers at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center along with colleagues at the Cleveland Clinic, the Veterans Administration Boston Healthcare and the National Cancer Institute, may prove to be a promising new tool in the diagnosis of prostate cancer. The study which will be...

2011-05-17 11:23:58

A new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional PSA test used today, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center. The test, called the A+PSA assay, also reduced the rate of false-positives, tests that indicate the presence of cancer when no disease is actually present, said Gang...